SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesequity

Definitive Healthcare Corp. (DH) News

Follow Definitive Healthcare Corp. (DH) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 15 public stories across 6 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol DH Asset equity Sector Markets 90 days 13 Last 1.215 Updated Nov 06, 2026, 02:05 PM UTC Open live news feed Open DH chart & news
M Definitive Healthcare Reports Third-Quarter 2026 Revenue of $54.7 Million Revenue fell 9% year over year to $54.7 million. The company reported a net loss of $5.4 million, compared with $17.8 million a year earlier, and adjusted EBITDA of $15.7 million versus $18.9 million. Operating cash flow EQUITY | Nov 06, 2026, 02:05 PM UTC M Definitive Healthcare Q3 Revenue Falls, Company Withholds Guidance EQUITY | Nov 05, 2026, 09:59 PM UTC L Definitive discloses TRA holders waive early termination payment through Dec. 31, 2026 Definitive Healthcare Corp. disclosed that certain TRA holders irrevocably waived their right to an Early Termination Payment for qualifying Change of Control transactions with definitive merger agreements executed on or MNA | Sep 09, 2026, 12:33 PM UTC L Definitive Healthcare names Clay Ritchey CEO, effective Sept. 8 Definitive Healthcare appointed Clay Ritchey as chief executive effective Sept. 8, succeeding Kevin Coop, who departed Aug. 31. The company said the departure wasn’t due to disagreement on operations or policies. EQUITY | Sep 02, 2026, 01:51 PM UTC M Definitive Healthcare receives Advent International acquisition interest at $1.02/share Definitive Healthcare said it received a notice of interest from Advent International to acquire it for $1.02 a share. The non-binding letter says the offer would be all-cash and take the company private. MNA | Sep 02, 2026, 01:29 PM UTC L Definitive Healthcare special committee confirms receipt of Advent going-private proposal Definitive Healthcare’s special committee said it has received a non-binding going-private proposal from Advent International, according to the company’s announcement. EQUITY | Sep 02, 2026, 01:17 PM UTC L DH special committee confirms receipt of going-private proposal Definitive Healthcare’s special committee confirms it received a going-private proposal from Advent International. EQUITY | Sep 02, 2026, 01:15 PM UTC L Definitive Healthcare names Clay Ritchey CEO, board member Definitive Healthcare appointed Clay Ritchey as chief executive officer and board member, effective September 8, 2026. Kevin Coop stepped down as CEO and board member effective August 31, 2026. REGULATION | Sep 02, 2026, 12:45 PM UTC M Advent International proposes to buy remaining Definitive Healthcare shares Advent International, L.P. holds a 58.54% stake in Definitive Healthcare’s Class A common stock and submitted a non-binding proposal on Sept. 1, 2026 to buy the rest it does not own, including a founder rollover. EQUITY | Sep 02, 2026, 12:38 PM UTC L Definitive Healthcare names Clay Ritchey as CEO Definitive Healthcare said its Board appointed Clay Ritchey as CEO. The company said he brings more than 25 years of healthcare expertise. EQUITY | Sep 02, 2026, 12:37 PM UTC L Definitive Healthcare: Ritchey succeeds Kevin Coop at DH Definitive Healthcare says Ritchey succeeds Kevin Coop at DH. EQUITY | Sep 02, 2026, 12:36 PM UTC L Definitive Healthcare appoints Clay Ritchey to board of directors Definitive Healthcare names Clay Ritchey as a member of its board of directors. EQUITY | Sep 02, 2026, 12:36 PM UTC L Definitive Healthcare appoints Clay Ritchey as CEO Definitive Healthcare appointed Clay Ritchey as CEO. EQUITY | Sep 02, 2026, 12:36 PM UTC L Definitive Healthcare Raises FY2026 Adj EPS Guidance from $0.16-$0.19 to $0.18-$0.20 vs $0.18 Est; Narrows FY2026 Sales Guidance from $220.0 Definitive Healthcare (NASDAQ: DH ) raises FY2026 Adj EPS guidance from $0.16-$0.19 to $0.18-$0.20 vs $0.18 analyst estimate. Narrows FY2026 sales outlook from $220.000 million-$226.000 million to $220.000 million-$222.0 EARNINGS | Aug 10, 2026, 08:11 PM UTC L DH - Definitive Healthcare Announces Timing of Its Second Quarter 2026 Financial Results Conference Call and Webcast DH - Definitive Healthcare Announces Timing of Its Second Quarter 2026 Financial Results Conference Call and Webcast EARNINGS | Aug 03, 2026, 08:06 PM UTC